NCT00102869View on ClinicalTrials.gov

Dopaminergic Enhancement of Learning and Memory in Aphasia

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

December 31, 2008

Conditions
Cerebrovascular AccidentAphasia
Interventions
DRUG

levodopa

100mg levodopa per day over 10 days/ treatment phase

Trial Locations (1)

48129

Dept. of Neurology, University Hospital Muenster, Münster

All Listed Sponsors
collaborator

German Federal Ministry of Education and Research

OTHER_GOV

lead

University Hospital Muenster

OTHER

NCT00102869 - Dopaminergic Enhancement of Learning and Memory in Aphasia | Biotech Hunter | Biotech Hunter